Related Articles
Survivin promoter-based conditionally replicative adenoviruses target cholangiocarcinoma
Development of an optimized conditionally replicative adenoviral agent for ovarian cancer
Incorporating the survivin promoter in an infectivity enhanced CRAd-analysis of oncolysis and anti-tumor effects in vitro and in vivo
Retargeting improves the efficacy of a telomerase-dependent oncolytic adenovirus for head and neck cancer
Oncolytic adenoviral vectors which employ the survivin promoter induce glioma oncolysis via a process of beclin-dependent autophagy